Somatic mutations in CDH1 occur frequently in diffuse gastric cancer (DGC) and lobular breast cancer (LBC) and its downregulation is a hallmark of the epithelial–mesenchymal transition [2, 3]. This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.